tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ABUS Stock Latest News

Strategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges
RatingsStrategic Legal Maneuvers Bolster Buy Rating for Arbutus Biopharma Amid Global Patent Challenges
5h ago
ABUS
Genevant and Arbutus File Global Patent Lawsuits Against Moderna
PremiumCompany Announcements
Genevant and Arbutus File Global Patent Lawsuits Against Moderna
6h ago
ABUS
Genevant, Arbutus initiate patent infringement actions against Moderna
PremiumThe Fly
Genevant, Arbutus initiate patent infringement actions against Moderna
7h ago
ABUS
MRNA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3d ago
IPA
PBM
Positive Outlook on Arbutus Biopharma Amid Strategic Focus and Legal Developments
PremiumRatings
Positive Outlook on Arbutus Biopharma Amid Strategic Focus and Legal Developments
5d ago
ABUS
Roivant Sciences announces replacement of Arbutus Biopharma board
PremiumThe FlyRoivant Sciences announces replacement of Arbutus Biopharma board
6d ago
ABUS
ROIV
Arbutus Biopharma appoints Lindsay Androski as CEO
Premium
The Fly
Arbutus Biopharma appoints Lindsay Androski as CEO
6d ago
ABUS
Arbutus Biopharma Overhauls Board and Appoints New CEO
Premium
Company Announcements
Arbutus Biopharma Overhauls Board and Appoints New CEO
6d ago
8K
ABUS
Is ABUS a Buy, Before Earnings?
PremiumPre-Earnings
Is ABUS a Buy, Before Earnings?
7d ago
ABUS
Arbutus Biopharma provides 2025 corporate, financial update
PremiumThe Fly
Arbutus Biopharma provides 2025 corporate, financial update
2M ago
ABUS
Jefferies says Arbutus, Roivant may benefit from bird flu headlines
PremiumThe Fly
Jefferies says Arbutus, Roivant may benefit from bird flu headlines
2M ago
ABUS
ROIV
Whitefort Capital sends letter to Arbutus Biopharma board of directors
PremiumThe Fly
Whitefort Capital sends letter to Arbutus Biopharma board of directors
3M ago
PFE
ABUS
Arbutus Biopharma Highlights Hepatitis B Treatment Advances
PremiumCompany AnnouncementsArbutus Biopharma Highlights Hepatitis B Treatment Advances
3M ago
ABUS
Arbutus Biopharma price target raised to $5 from $4.50 at Chardan
Premium
The Fly
Arbutus Biopharma price target raised to $5 from $4.50 at Chardan
3M ago
ABUS
Arbutus Biopharma’s Promising cHBV Treatment Results
Premium
Company Announcements
Arbutus Biopharma’s Promising cHBV Treatment Results
4M ago
ABUS
Arbutus Biopharma’s Trial Boosts Hepatitis B Treatment
PremiumCompany Announcements
Arbutus Biopharma’s Trial Boosts Hepatitis B Treatment
4M ago
ABUS
Arbutus Biopharma announces new data from IM-PROVE I Phase 2a trial
PremiumThe Fly
Arbutus Biopharma announces new data from IM-PROVE I Phase 2a trial
4M ago
ABUS
Arbutus and Barinthus announce new data from IM-PROVE II trial
PremiumThe Fly
Arbutus and Barinthus announce new data from IM-PROVE II trial
4M ago
ABUS
BRNS
Arbutus Biopharma to Present at Jefferies Conference
PremiumCompany Announcements
Arbutus Biopharma to Present at Jefferies Conference
4M ago
ABUS
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe FlyJMP Securities healthcare analysts hold an analyst/industry conference call
4M ago
GSK
VIR
Arbutus Biopharma price target raised to $4.50 from $4 at Chardan
Premium
The Fly
Arbutus Biopharma price target raised to $4.50 from $4 at Chardan
4M ago
ABUS
Arbutus Biopharma files $300M mixed securities shelf
Premium
The Fly
Arbutus Biopharma files $300M mixed securities shelf
4M ago
ABUS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >